Patients,Investigators and Pharmaceuticals Working Together to Accelerate Research and Access: The Lung Cancer Master Protocol (Lung-MAP) Clinical Trial - Vassiliki Papadimitrakopoulou (USA)
Chairs: Jaime de la Garza (Mexico), Andreas Rimner (USA), Anne Tsao (USA)
Case 1: A 70 Year Old with a Biphasic Stage I MPM - TBA
Case 2: A 65 Year Old with an Uncytoreduceable MPM - Paul Baas (Netherlands)
Case 3: A 65 Year Old with a Clinical Stage II MPM and Chest Pain - Joseph Friedberg (USA)
Addressing the Needs of the Mesothelioma Patient Who Has Exhausted Treatment Options: Palliation and Support for Family and Patient - Helen Clayson (United Kingdom); Liz Darlison (UK); Mary Hesdorffer (USA)
Assessment of immune Cells in Tumor Biopsies as a Biomarker - Elisabeth Brambilla (France)
Search for Genetic/Molecular Predictors of Immune Checkpoint Therapy - Role of KRAS, LKB1, Other Genetic Markers as Predictors for Immunotherapy - Scott Gettinger (USA)